Skip to main content
Equibles
USPH logo

USPH · U S Physical Therapy Inc · Metrics

Track USPH — free

Use USPH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research USPH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$85.32 -2.02 (-2.31%) At close · Oct 28 Q1 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.29B
Shares
14.92M
Volume · Oct 28 187.31K Avg daily vol (3M) 191.75K

USPH metrics

110 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$85.32
Market cap
$1.29B

Price action

20 metrics
Price change (1W)
+0.4%
Price change (30D)
+1.5%
Price change (3M)
+10.6%
Price change (6M)
+20.4%
Price change (YTD)
+11.8%
Price change (1Y)
-4.0%
Trailing year
Price change (5Y)
-14.5%
52-week high
$91.00
52-week low
$59.00
Change from 52-week high
-4.0%
Change from 52-week low
+48.0%
Annualized volatility
38.6%
Annualized volatility (3M)
24.7%
Beta
0.6
RSI (14D)
58.8
Price vs SMA 50
+6.0%
Price vs SMA 200
+13.8%
Avg volume (3M)
192,028
Relative volume
1.0
Average dollar volume
$15.63M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
14.92M

Valuation

12 metrics
P / E (TTM)
513.8
Trailing earnings · reciprocal yield 0.2%
PEG ratio
—
EV / revenue
1.8×
reciprocal yield 54.3%
EV / EBITDA
15.1×
reciprocal yield 6.6%
EV / EBIT
19.6×
reciprocal yield 5.1%
P / sales
1.6×
reciprocal yield 62.4%
P / book
2.9
reciprocal yield 34.5%
FCF yield
4.9%
TTM · current market cap
Buyback yield
1.9%
P / FCF
20.3
reciprocal yield 4.9%
P / operating cash flow
15.7
reciprocal yield 6.4%
Earnings yield
2.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.0×
reciprocal yield 48.8%
EV / revenue historical average (5Y)
2.3×
reciprocal yield 43.5%
EV / EBIT historical average (3Y)
22.1×
reciprocal yield 4.5%
EV / EBIT historical average (5Y)
21.7×
reciprocal yield 4.6%
EV / EBITDA historical average (3Y)
16.6×
reciprocal yield 6.0%
EV / EBITDA historical average (5Y)
16.9×
reciprocal yield 5.9%

Dividends & buybacks

7 metrics
Dividend yield
2.1%
Trailing 12 months
Payout ratio
—
Shareholder yield
4.0%
Dividend / share (TTM)
$1.83
Dividend growth YoY
+2.2%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-08-21

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
18.7%
Operating margin
9.4%
Trailing 12 months
Net margin
4.0%
Gross profit (TTM)
$151.70M
Operating profit (TTM)
$76.52M
Net income (TTM)
$32.23M
Trailing 12 months
Diluted EPS (TTM)
$0.17
FCF margin
7.9%
Effective tax rate
26.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$53.61
Gross profit per diluted share (TTM)
$10.01
Operating profit per diluted share (TTM)
$5.05
EBITDA per diluted share (TTM)
$6.53
Net income per diluted share (TTM)
$2.13
Operating cash flow per diluted share (TTM)
$5.49
Free cash flow per diluted share (TTM)
$4.23
Capital expenditures per diluted share (TTM)
$1.25
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.65
Book value per share
$17.02

Growth

11 metrics
Revenue growth YoY
+8.5%
Year over year
Net income growth YoY
-20.1%
Revenue (TTM)
$812.20M
Trailing 12 months
EPS growth YoY
-56.9%
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+12.2%
Revenue CAGR (5Y)
+13.0%
EPS CAGR (3Y)
-14.2%
EPS CAGR (5Y)
-10.6%
FCF CAGR (3Y)
+6.6%
FCF CAGR (5Y)
-8.0%

Quality

14 metrics
Return on equity
7.2%
Return on assets
2.6%
Debt / equity
0.5
Current ratio
1.3
EBITDA (TTM)
$98.93M
Free cash flow (TTM)
$64.07M
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
2.0
Return on invested capital
8.8%
Trailing 12 months
Net cash
−$195.13M
Latest balance sheet
Cash & equivalents
$24.89M
Total assets
$1.25B
Total debt
$220.02M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$83.05M
Capital expenditures (TTM)
$18.98M
R&D (TTM)
—
SG&A (TTM)
$72.82M
Stock compensation (TTM)
$9.86M
R&D / revenue
—
Stock compensation / revenue
1.2%

Ownership (13F)

9 metrics
13F filers
219
13F filer change QoQ
-10
Institutional ownership
108.6%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.0%
Holder tenure
18.0
Price vs estimated holder cost
-20.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
25.1%

Short interest

3 metrics
Short interest
8.0%
Latest settlement · 6.6 days to cover
Days to cover
6.6d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
$395
Insider-sentiment score
70 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 885978 CUSIP 90337L108 13F (30d) 60 filings 55 filers Visit website Investor relations